このページは自動翻訳されたものであり、翻訳の正確性は保証されていません。を参照してください。 英語版 ソーステキスト用。

経大腿切断患者におけるオズールパワーニーの生体力学的評価 (OPKTFA)

2026年9月17日 更新者:VA Office of Research and Development

電動人工膝関節の屈曲および伸展を備えた経大腿人工関節は可動性を向上させますか?オズールパワーニーの生体力学的評価

Microprocessor-controlled knees (MPKs) do not typically utilize motors to power joint rotation, but they automatically adjust resistance or damping in the joint to improve swing- and/or stance-phase control as appropriate for the prosthesis user during gait. The Ossur Power Knee is the only commercially-available MPK that uses a motor to provide active power generation during walking and other activities. The purpose of this proposed investigation is to perform and compare biomechanical evaluations of the Power Knee and Ossur Rheo XC, a passive MPK, during walking and other activities by prosthesis users. Furthermore, mobility between male and female subjects will be compared to determine if there are differences in prosthetic knee usage on the basis of sex.

調査の概要

詳細な説明

The anatomical knee is a complex, polycentric joint characterized by a large range of motion in the sagittal plane and limited mobility in the coronal and transverse planes. The sagittal plane motion is used for progression in stance phase, and limb clearance and advancement in swing. Limb prostheses are intended to restore function and cosmesis in persons with limb loss. The complexity and function of prosthetic components have advanced significantly as technology has improved, but a state-of-the-art artificial limb is still a relatively poor substitute for an anatomical one. Microprocessor-controlled knees (MPKs) do not typically utilize motors to power joint rotation, but they automatically adjust resistance or damping in the joint to improve swing- and/or stance-phase control as appropriate for the user during gait. The Ossur Power Knee, which was first introduced in 2006, is the only MPK that uses a motor to provide active power generation during walking and other activities involving knee flexion and extension. Last year, Ossur released the 3rd generation of its Power Knee and appears to have addressed many of the previous shortcomings in terms of reduced weight, less noise, lower cost and longer battery life. Therefore, the newest version of the Power Knee warrants a fresh evaluation since it is, in essence, substantially different in design and function from previous models.

The purpose of this proposed investigation is to perform biomechanical evaluations of the new Ossur Power Knee during walking and other activities by transfemoral prosthesis users. Using a cross-over experimental design, approximately 20 unilateral, transfemoral amputee subjects (10 men and 10 women) will be evaluated in the Jesse Brown VAMC Motion Analysis Research Laboratory (MARL) while wearing the Ossur Power Knee and Ossur Rheo XC, which is a passive MPK device. Furthermore, the Ossur Power Knee may offer distinct advantages to female prosthesis users, so mobility will be compared between men and women to determine if differences exist on the basis of sex. The specific aims and hypotheses of this project are:

Aim 1: To compare the effects of the Ossur Power Knee and Ossur Rheo XC on the gait of unilateral, transfemoral prosthesis users during level walking. Kinematic and kinetic data will be collected as subjects walk in the MARL. Hypothesis--the active knee flexion and extension provided by the Ossur Power Knee will (1) improve walking performance, and (2) reduce metabolic energy cost during ambulation.

Aim 2: To compare the effects of the Ossur Power Knee and Ossur Rheo XC on stairs, slopes and during sit-to-stand/stand-to-sit activities of unilateral, transfemoral prosthesis users. Kinematic data will be collected as subjects perform these activities. Hypothesis--subjects will have improved performance when using the Ossur Power Knee.

Aim 3: To analyze and compare gender specific data between subjects using the Ossur Power Knee and the Ossur Rheo XC. Hypothesis--male and female subjects will demonstrate substantially different abilities to use the two knee components, indicating that gender specific components should be further investigated and developed. Research focusing on the unique prosthetic needs of women Veterans is currently a special emphasis area of the VA RR&D Service.

Subjects will also be administered questionnaires and provided at-home diaries to document their perceptions of comfort, exertion and stability while using the different prosthetic knee units.

The repeated-measures, cross-over protocol design enables each subject to serve as their own control, and it will be determined whether statistically significant changes occur in their performance measures. A two-way mixed-methods ANOVA will be used to assess the main and interaction effects of sex (male, female) and knee type (Ossur Power Knee, Rheo XC). As a conservative approach, a Bonferroni correction will be used to account for the family-wise Type I error rate because multiple outcomes will be used to address each hypothesis.

Increased understanding about how the Ossur Power Knee affects the abilities of transfemoral prosthesis users will facilitate appropriate component selection by prosthetists and ultimately improve quality of life for prosthesis users.

研究の種類

介入

入学 (推定)

20

段階

  • 適用できない

連絡先と場所

このセクションには、調査を実施する担当者の連絡先の詳細と、この調査が実施されている場所に関する情報が記載されています。

研究連絡先

研究連絡先のバックアップ

  • 名前:Steven A Gard, PhD
  • 電話番号:(312) 503-5718
  • メール:steven.gard@va.gov

研究場所

    • Illinois
      • Chicago、Illinois、アメリカ、60612
        • 募集
        • Jesse Brown VA Medical Center, Chicago, IL
        • コンタクト:
        • 主任研究者:
          • Steven A Gard, PhD
        • コンタクト:

参加基準

研究者は、適格基準と呼ばれる特定の説明に適合する人を探します。これらの基準のいくつかの例は、人の一般的な健康状態または以前の治療です。

適格基準

就学可能な年齢

45年~75年 (大人、高齢者)

健康ボランティアの受け入れ

いいえ

受講資格のある性別

全て

説明

Inclusion Criteria:

  • Unilateral, transfemoral amputation (any etiology)
  • Residual limb length classified as standard (i.e., medium) to long
  • Prosthesis user for at least 1 year prior to enrolling in the study
  • K3 or K4 level ambulator
  • Good sensation on their residual limb(s) (upon routine clinical examination)
  • Good skin integrity upon visual inspection
  • Does not require the use of assistive devices to walk for short distances
  • Not currently taking medications that are known to affect balance or gait
  • Presents with good socket fit based upon a standard assessment by the study prosthetist

Exclusion Criteria:

  • Bilateral amputations
  • Individuals with a knee disarticulation

研究計画

このセクションでは、研究がどのように設計され、研究が何を測定しているかなど、研究計画の詳細を提供します。

研究はどのように設計されていますか?

デザインの詳細

  • 主な目的:処理
  • 割り当て:ランダム化
  • 介入モデル:クロスオーバー割り当て
  • マスキング:なし(オープンラベル)

武器と介入

参加者グループ / アーム
介入・治療
実験的:Ossur Power Knee

Subjects will be fitted with the Ossur Power Knee, which has powered flexion and extension.

Subjects will be fitted and trained on the Ossur Power Knee. An accommodation of 1 month will be provided prior to evaluation with the knee joint.

他の名前:
  • オッサーパワーニー
アクティブコンパレータ:Ossur Rheo XC Knee

Subjects will be fitted with the Ossur Rheo XC Knee, which is a conventional microprocessor-controlled prosthetic knee joint that modulates the amount of damping during flexion and extension.

Subjects will be fitted and trained on the Ossur Rheo XC Knee. An accommodation of 1 month will be provided prior to evaluation with the knee joint.

他の名前:
  • Ossur Rheo

この研究は何を測定していますか?

主要な結果の測定

結果測定
メジャーの説明
時間枠
Walking speed
時間枠:To be measured after the 1-month accommodation period of wearing each prosthetic knee component

Walking speed will be measured as participants walk on level ground at slow, normal and fast speeds.

To be measured after the 1-month accommodation period of wearing each prosthetic knee component
Metabolic energy cost
時間枠:To be measured after the 1-month accommodation period of wearing each prosthetic knee component

The metabolic energy rate will be measured as subjects walk at their freely selected speed on a level treadmill, which will be converted to metabolic energy cost (energy expended per unit distance).

To be measured after the 1-month accommodation period of wearing each prosthetic knee component
Sit-to-stand/stand-to-sit symmetry
時間枠:To be measured after the 1-month accommodation period of wearing each prosthetic knee component

Knee kinematics and load distribution between the sound and prosthetic sides will be measured as participants stand up and sit down in a chair.

To be measured after the 1-month accommodation period of wearing each prosthetic knee component

二次結果の測定

結果測定
メジャーの説明
時間枠
Step length
時間枠:To be measured after the 1-month accommodation period of wearing each prosthetic knee component

The step lengths of the sound and prosthetic sides will be measured as participants walk on level ground at slow, normal and fast speeds.

To be measured after the 1-month accommodation period of wearing each prosthetic knee component
Toe clearance during swing phase
時間枠:To be measured after the 1-month accommodation period of wearing each prosthetic knee component

Toe clearance during swing phase on the prosthetic side will be measured as participants walk on level ground at slow, normal and fast speeds.

To be measured after the 1-month accommodation period of wearing each prosthetic knee component
Sound leg loading rate
時間枠:To be measured after the 1-month accommodation period of wearing each prosthetic knee component

The sound leg loading rate during walking will be measured as participants walk on level ground at slow, normal and fast speeds.

To be measured after the 1-month accommodation period of wearing each prosthetic knee component
Kinematics of pelvic motion
時間枠:To be measured after the 1-month accommodation period of wearing each prosthetic knee component

Pelvic tilt, rotation and obliquity will be measured as participants walk on level ground at slow, normal and fast speeds.

To be measured after the 1-month accommodation period of wearing each prosthetic knee component

協力者と研究者

ここでは、この調査に関係する人々や組織を見つけることができます。

捜査官

  • 主任研究者:Steven A Gard, PhD、Jesse Brown VA Medical Center, Chicago, IL

研究記録日

これらの日付は、ClinicalTrials.gov への研究記録と要約結果の提出の進捗状況を追跡します。研究記録と報告された結果は、国立医学図書館 (NLM) によって審査され、公開 Web サイトに掲載される前に、特定の品質管理基準を満たしていることが確認されます。

主要日程の研究

研究開始 (実際)

2024年4月1日

一次修了 (推定)

2027年1月31日

研究の完了 (推定)

2027年3月31日

試験登録日

最初に提出

2024年1月11日

QC基準を満たした最初の提出物

2024年1月11日

最初の投稿 (実際)

2024年1月23日

学習記録の更新

投稿された最後の更新 (実際)

2026年9月22日

QC基準を満たした最後の更新が送信されました

2026年9月17日

最終確認日

2026年9月1日

詳しくは

本研究に関する用語

その他の研究ID番号

  • A4541-R
  • RX004541-01A2 (その他の助成金/資金番号:VA RRD)
  • 5I01RX004541-02 (米国 NIH グラント/契約)

個々の参加者データ (IPD) の計画

個々の参加者データ (IPD) を共有する予定はありますか?

いいえ

IPD プランの説明

A Limited Dataset (LDS) will be created and shared pursuant to a Data Use Agreement (DUA) appropriately limiting use of the dataset and prohibiting the recipient from identifying or re-identifying (or taking steps to identify or re-identify) any individual whose data are included in the dataset. Results from this study will be freely disseminated via presentations at professional conferences and publications in scientific journals. Additionally, data acquired for this project will be shared with those investigators who make a formal request to the PI and can demonstrate a legitimate and justifiable cause for utilization of such data. All requests for these data will be discussed with the VA scientific program manager.

医薬品およびデバイス情報、研究文書

米国FDA規制医薬品の研究

いいえ

米国FDA規制機器製品の研究

いいえ

米国で製造され、米国から輸出された製品。

いいえ

この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。

購読する